PIRS Pieris Pharmaceuticals a Sleeping Giant ??

NASDAQ:PIRS   Pieris Pharmaceuticals, Inc
PIRS Pieris Pharmaceuticals has collaboration agreements with AstraZeneca, Boston Pharmaceuticals, Servier, Seagen and Genentech, part of Roche.

AZN AstraZeneca 70Mil upfront payment and 5.4Bil potential milestone payments
Boston Pharmaceuticals 10Mil upfront payment and 353Mil potential milestone payments
Genentech member of RHHBY Roche Group 20Mil upfront payment and 1.4Bil potential milestone payments
SGEN Seagen 35Mil upfront payment and 1.2Bil potential milestone payments
Servier 40Mil upfront payment and 447Mil potential milestone payments

So a best case scenario company with 9Bil Revenue

PIRS Pieris Pharmaceuticals Market Cap is only 254Mil now!!!

On 4/26/2021 HC Wainwright Brokerage set up a price target for PIRS at $9.00 per share.

What do you think it`s the real upside potential of Pieris Pharmaceuticals??

PIRS was on my private calls list since 3.42usd.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.